Need a specific person's email?
Browse Active Biotech AB's employee directory (about 19 employees) and reveal verified emails free.
Active Biotech AB's most common email format is First.Last@activebiotech.com (ex. John.Doe@activebiotech.com), used for 86% of activebiotech.com addresses. Active Biotech AB uses 4 email patterns.
| Format | Example | Share of activebiotech.com |
|---|---|---|
| First.Last@activebiotech.comMost common | John.Doe@activebiotech.com | |
| Last@activebiotech.com | Doe@activebiotech.com | |
| FirLast@activebiotech.com | JohDoe@activebiotech.com | |
| LastFi@activebiotech.com | DoeJo@activebiotech.com |
Browse Active Biotech AB's employee directory (about 19 employees) and reveal verified emails free.
Biotechnology ResearchSkåne, Sweden11-50 Employees
Active Biotech AB is a biotechnology company focused on developing first-in-class immunomodulatory therapies for oncology and immunology with high unmet medical need. Following a portfolio refocus, the company aims to move programs into clinical development and then advance them internally or pursue partnerships. The portfolio centers on tasquinimod and laquinimod, small-molecule modulators that influence myeloid immune cell function, with tasquinimod studied in multiple myeloma and laquinimod progressing toward ophthalmic applications for non-infectious uveitis. Naptumomab, a targeted cancer immunotherapy, is partnered with NeoTX Therapeutics for a phase Ib/II program in advanced solid tumors. A notable recent development is the 2024 collaboration with MD Anderson Cancer Center to conduct a tasquinimod clinical study in myelofibrosis. The company is headquartered in Lund, Skåne, and is listed on NASDAQ Stockholm.
Most common format
First.Last@activebiotech.com
Example: John.Doe@activebiotech.com
Free with a LeadIQ account. No credit card.
Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.